144 related articles for article (PubMed ID: 27977770)
1. Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle.
Spaulding HR; Ballmann CG; Quindry JC; Selsby JT
PLoS One; 2016; 11(12):e0168293. PubMed ID: 27977770
[TBL] [Abstract][Full Text] [Related]
2. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
[TBL] [Abstract][Full Text] [Related]
3. Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.
Selsby JT; Ballmann CG; Spaulding HR; Ross JW; Quindry JC
J Physiol; 2016 Oct; 594(20):6037-6053. PubMed ID: 27094343
[TBL] [Abstract][Full Text] [Related]
4. Long-term quercetin dietary enrichment decreases muscle injury in mdx mice.
Hollinger K; Shanely RA; Quindry JC; Selsby JT
Clin Nutr; 2015 Jun; 34(3):515-22. PubMed ID: 24998094
[TBL] [Abstract][Full Text] [Related]
5. Long-term dietary quercetin enrichment as a cardioprotective countermeasure in mdx mice.
Ballmann C; Denney T; Beyers RJ; Quindry T; Romero M; Selsby JT; Quindry JC
Exp Physiol; 2017 Jun; 102(6):635-649. PubMed ID: 28192862
[TBL] [Abstract][Full Text] [Related]
6. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
[TBL] [Abstract][Full Text] [Related]
7. Nutraceutical and pharmaceutical cocktails did not preserve diaphragm muscle function or reduce muscle damage in D2-mdx mice.
Spaulding HR; Quindry T; Quindry JC; Selsby JT
Exp Physiol; 2020 Jun; 105(6):989-999. PubMed ID: 32267561
[TBL] [Abstract][Full Text] [Related]
8. Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment.
Ballmann C; Hollinger K; Selsby JT; Amin R; Quindry JC
Exp Physiol; 2015 Jan; 100(1):12-22. PubMed ID: 25557727
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice.
Wineinger MA; Abresch RT; Walsh SA; Carter GT
Am J Phys Med Rehabil; 1998; 77(1):20-7. PubMed ID: 9482375
[TBL] [Abstract][Full Text] [Related]
11. PGC-1α gene transfer improves muscle function in dystrophic muscle following prolonged disease progress.
Hollinger K; Selsby JT
Exp Physiol; 2015 Oct; 100(10):1145-58. PubMed ID: 26268822
[TBL] [Abstract][Full Text] [Related]
12. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
[TBL] [Abstract][Full Text] [Related]
13. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.
Schertzer JD; Gehrig SM; Ryall JG; Lynch GS
Am J Pathol; 2007 Oct; 171(4):1180-8. PubMed ID: 17823291
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
15. Voluntary physical activity protects from susceptibility to skeletal muscle contraction-induced injury but worsens heart function in mdx mice.
Hourdé C; Joanne P; Medja F; Mougenot N; Jacquet A; Mouisel E; Pannerec A; Hatem S; Butler-Browne G; Agbulut O; Ferry A
Am J Pathol; 2013 May; 182(5):1509-18. PubMed ID: 23465861
[TBL] [Abstract][Full Text] [Related]
16. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
17. Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.
Selsby JT; Morine KJ; Pendrak K; Barton ER; Sweeney HL
PLoS One; 2012; 7(1):e30063. PubMed ID: 22253880
[TBL] [Abstract][Full Text] [Related]
18. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
[TBL] [Abstract][Full Text] [Related]
19. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.
Gregorevic P; Plant DR; Lynch GS
Muscle Nerve; 2004 Sep; 30(3):295-304. PubMed ID: 15318340
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]